Reimbursement benefit for Guerbet Korea’s liver cancer contrast medium Lipiodol Ultra-Fluid (iodised oil, 12.8g/10mL) will be extended to lymphangiography and sialography. On the other hand, reimbursement benefit for Chong Kun Dang Pharmaceutical’s avocado and soyabeam unsaponifiables, Imotun Cap., will be reduced in line with its reduced indication.

The Ministry of Health and Welfare made a partial amendment and issued the ‘Details on the applied standards and methods of medical benefits (drugs)’ that contained the abovementioned changes. The changes will apply on different dates for each drug.

First, the reimbursement benefit for the liver cancer contrast medium Lipiodol Ultra-Flu